Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
UK stocks finished modestly in the red on Monday amid thin trading on a US public holiday, with a cut to global growth forecasts from the IMF weighing on European markets at the start of the week.
The Washingon-based organisation now expects the global economy to expand by 3.3% in 2020, a slight downwards revision from the IMF's 3.4% estimate from 3 months ago.
At 16.35, the benchmark FTSE 100 index was down 23.12 points, or 0.3%, at 7,651.44, while the FTSE 250 traded 39 points lower at 21,847.
LARGE AND MID CAP RISERS AND FALLERS
Fevertree Drinks sank 28.5% to £14.27 as it warned on profits, after subdued Christmas trading in the UK limited its annual revenue growth to a disappointing 10%.
Defence company BAE Systems rose 3.5% to 646.4p, on announcing that it had agreed to acquire Collins Aerospace's global positioning system business for $1.93bn.
BAE also agreed to acquire Raytheon's airborne tactical radios business for $275m.
Mining company Anglo American softened 1p to £22.45 after making a formal £404.9m takeover bid for Sirius Minerals, which was accepted by the British fertilizer hopeful's board.
Sirius Minerals rose 2.4% to 5.53p, a smidgeon ahead of the 5.5p bid price.
SMALL CAP RISERS AND FALLERS
Car parts-to-bicycles retailer Halfords motored 6.4% higher to 161.7p on the revelation chairman Keith Williams bought £77,000 worth of shares on Friday.
Mall operator Intu Properties slipped 2.5% to 22.3p after it revealed plans to conduct an equity raising.
Economic infrastructure financing specialist Sequoia Economic Infrastructure Fund fell 1% to 117.4p, as it too flagged a potential equity raise.
Online women's fashion retailer Sosandar reversed 7.1% to 26.25p, having warned that it would report a deeper-than-expected annual loss despite a jump in revenue, as it continued to invest in customer acquisition.
Waste-to-products group Renewi shed 5.1% to trade at 34.8p after warning that it would record a €25.5m exceptional charge in its annual results, owing to a new Dutch tax and Brexit hurting a key contract in Holland.
Immunotherapy developer for cancer Scancell jumped 17.6% to 7.35p after it signed a collaboration and research agreement with a US-based, clinical-stage antibody company that it did not identify.
Cell-based therapies company MaxCyte rallied 9.8% to 135p on announcing that it was trading ahead of market expectations, as sales growth accelerated in the second half.
Advice-led wealth manager AFH Financial firmed up 1.3% to 390p after reporting strong revenue growth, up 47% to £74.3m for the year to October, and assuring that trading remains strong and in line with the board's expectations.